J Cancer 2016; 7(9):1074-1080. doi:10.7150/jca.14031 This issue


TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance

Hong Ren1, Peizhun Du1, Zongyu Ge2, Yiting Jin1, Di Ding3, Xiuping Liu4, Qiang Zou1✉

1. Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, P.R. China
2. Department of General Surgery, Huzhou Maternity and Child Health Care Hospital, Zhejiang Province, P.R. China
3. Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, P.R. China
4. Department of Pathology, Shanghai Medical College, Fudan University, Shanghai, P.R. China

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Ren H, Du P, Ge Z, Jin Y, Ding D, Liu X, Zou Q. TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance. J Cancer 2016; 7(9):1074-1080. doi:10.7150/jca.14031. Available from https://www.jcancer.org/v07p1074.htm

File import instruction


Purpose Increasing evidences revealed that cancer cells with the characteristics of epithelial-mesenchymal transition (EMT) or cancer stem cells (CSC) have high ability of progression, invasion, metastasis and chemoresistance. TWIST1 and BMI1 are crucial transcription factors required for EMT and CSC. Both TWIST1 and BMI1 are up-regulated in various cancers and have a positive correlation with poor prognosis. Although recent results showed that the two molecules function in promoting cancer metastasis and chemoresistance respectively, the correlation of TWIST1 and BMI1 is not well understood.

Methods In this review, we summarize recent advance in cancer research focus on TWIST1 and BMI1 in cancer metastasis and chemoresistance, and emphasize the possible link between EMT and CSC.

Results Further investigation of TWIST1 and BMI1 cooperately promote CSC proliferation due to EMT-associated effect will help to understand the mechanism of tumor cells metastasis and chemoresistance.

Conclusions TWIST1 and BMI1 in cancer cells will be effective targets for treating chemoresistant metastatic lesions.

Keywords: epithelial-mesenchymal transition, cancer metastasis, chemoresistance, cancer stem cells